December 9, 2009

Mayo Clinic linked biotech plans estimated $74M IPO

By Kelley Luckstein

A Belgium biotech company that licenses Mayo Clinic research and is partially owned by Mayo - Cardio3 BioSciences Cardio3 BioSciences is licensing Mayo Clinic research about "differentiating" stem cells, or turning generic stem cells from bone marrow into cardiac cells. 


Post-Bulletin, by Jeff Kiger, 12/8/09

Tags: biotech, Cardio3 BioSciences, Research

Please sign in or register to post a reply.
Contact Us · Privacy Policy